PBLA Insider Trading

Insider Ownership Percentage: 0.11%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $51,730.60

Panbela Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Panbela Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Panbela Therapeutics Share Price & Price History

Current Price: $0.59
Price Change: Price Increase of +0.01 (1.72%)
As of 04/12/2024 01:00 AM ET

This chart shows the closing price history over time for PBLA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Panbela Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/8/2023Goldman Sachs Group IncMajor ShareholderSell3,643$14.20$51,730.6019,897View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Panbela Therapeutics (NASDAQ:PBLA)

4.37% of Panbela Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at PBLA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Panbela Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2023Walleye Capital LLC94,536$0.22M0.0%N/A16.881%Search for SEC Filing on Google Icon
8/15/2023Hudson Bay Capital Management LP76,000$0.18M0.0%-78.6%13.571%Search for SEC Filing on Google Icon
5/19/2023Anson Funds Management LP163,024$72K0.0%N/A0.971%Search for SEC Filing on Google Icon
5/16/2023Hudson Bay Capital Management LP355,000$0.16M0.0%N/A2.115%Search for SEC Filing on Google Icon
5/16/2023CVI Holdings LLC394,901$0.18M0.1%N/A2.352%Search for SEC Filing on Google Icon
5/16/2023Sabby Management LLC426,363$0.19M0.2%N/A2.540%Search for SEC Filing on Google Icon
5/16/2023Altium Capital Management LP335,324$0.15M0.1%N/A1.998%Search for SEC Filing on Google Icon
5/15/2023Anson Funds Management LP163,024$72K0.0%N/A0.971%Search for SEC Filing on Google Icon
5/12/2023HRT Financial LP68,549$30K0.0%N/A0.408%Search for SEC Filing on Google Icon
11/15/2022Vanguard Group Inc.222,303$60K0.0%N/A0.701%Search for SEC Filing on Google Icon
11/14/2022Armistice Capital LLC2,176,809$0.59M0.0%N/A5.324%Search for SEC Filing on Google Icon
11/10/2022UBS Group AG190,493$51K0.0%+46,589.5%0.466%Search for SEC Filing on Google Icon
11/2/2022Clear Street LLC110,500$30K0.0%N/A0.532%Search for SEC Filing on Google Icon
4/7/2022Fieldpoint Private Securities LLC62,621$0.13M0.0%-33.7%0.466%Search for SEC Filing on Google Icon
2/14/2022Murchinson Ltd.136,753$0.24M0.0%-8.8%1.018%Search for SEC Filing on Google Icon
1/24/2022Fieldpoint Private Securities LLC94,521$0.16M0.0%-31.8%0.704%Search for SEC Filing on Google Icon
11/12/2021Fieldpoint Private Securities LLC138,660$0.30M0.1%-5.4%1.033%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.29,359$64K0.0%+22.2%0.219%Search for SEC Filing on Google Icon
8/16/2021Warberg Asset Management LLC11,567$33K0.0%N/A0.086%Search for SEC Filing on Google Icon
8/13/2021Murchinson Ltd.150,000$0.43M0.2%N/A1.117%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.217,198$0.62M0.0%+941.8%1.618%Search for SEC Filing on Google Icon
8/12/2021Fieldpoint Private Securities LLC146,500$0.36M0.1%-20.4%1.091%Search for SEC Filing on Google Icon
8/11/2021CVI Holdings LLC41,667$0.12M0.0%N/A0.310%Search for SEC Filing on Google Icon
8/6/2021Buckingham Strategic Wealth LLC24,927$71K0.0%N/A0.186%Search for SEC Filing on Google Icon
5/19/2021Squarepoint Ops LLC15,538$61K0.0%N/A0.154%Search for SEC Filing on Google Icon
5/18/2021Verition Fund Management LLC20,000$79K0.0%-67.0%0.198%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC345,013$1.36M0.0%N/A3.420%Search for SEC Filing on Google Icon
4/23/2021Fieldpoint Private Securities LLC184,000$0.73M0.2%N/A1.824%Search for SEC Filing on Google Icon
2/18/2021Verition Fund Management LLC60,606$0.22M0.0%N/A0.628%Search for SEC Filing on Google Icon
2/17/2021Worth Venture Partners LLC21,794$78K0.1%N/A0.226%Search for SEC Filing on Google Icon
2/13/2021Essex Investment Management Co. LLC63,079$0.23M0.0%N/A0.654%Search for SEC Filing on Google Icon
2/1/2021Brand Asset Management Group Inc.57,144$0.20M0.1%N/A0.592%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Panbela Therapeutics logo
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, develops disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The company's lead product candidates are Ivospemin (SBP-101), which has completed Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma; FlynpoviTM, a combination of eflornithine (CPP-1X) and sulindac which is in Phase III clinical trials; and Eflornithine, an enzyme-activated irreversible inhibitor of the enzyme ornithine decarboxylase. It has a research agreement with the Johns Hopkins University School of Medicine for the development of Panbela's investigative agent ivospemin. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Read More on Panbela Therapeutics

Today's Range

Now: $0.59
Low: $0.49
High: $0.60

50 Day Range

MA: $0.88
Low: $0.55
High: $1.36

52 Week Range

Now: $0.59
Low: $0.41
High: $477.00

Volume

142,976 shs

Average Volume

53,040 shs

Market Capitalization

$2.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.48

Who are the company insiders with the largest holdings of Panbela Therapeutics?

Panbela Therapeutics' top insider shareholders include:
  1. Goldman Sachs Group Inc (Major Shareholder)
Learn More about top insider investors at Panbela Therapeutics.